Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03528408 |
| Title | Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Suthee Rapisuwon |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94158 | United States | Details | |
| Georgetown University | Washington D.C. | District of Columbia | 20057 | United States | Details | |
| Northwestern Univeristy Feinberg School of Medicine | Chicago | Illinois | 60611 | United States | Details | |
| Washington University School of Medicine | St Louis | Missouri | 63110 | United States | Details | |
| Columbia University | New York | New York | 10032 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |